Side effects in girls with Turner syndrome treated with growth hormone

Among 8457 children undergoing treatment with genotropin included in the database of international growth monitoring of the Kabi Pharmacia firm (KIGS) until June 1992, 818 patients were with Turner syndrome (TS). Side effects, classified as “serious” and “not serious”, were registered in 62. Based on the data regarding side effects, it can be assumed that the clinical tolerance of growth hormone (GH) in TS is comparable to that observed in the treatment of GR in patients with GH deficiency.